Acadia Pharmaceuticals (ACAD) shares ended the last trading session 6.1% higher at $14.96. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

CEOs exercise warrants early, signaling bullish confidence ahead of a key Phase 3 trial data release. Read more here.

NEW YORK, NY / ACCESS Newswire / April 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...